Kas Gevşeticiler

Butterworth.J. ,Mackey D., Wasnick.J(2015) Morgan & Mikhail Klinik Anesteziyoloji, (Prof. Dr. F. Handan Cuhruk Çev.Ed.)Ankara:Güneş Tıp Kitapevi

Hall Z, Merlie JR. Synaptic structure and devolepment: The neuromuscular junction. Cell 1993;72:99-121.

Huh KH, Fuhrer C. Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses. Mol Neurobiol 2002;25:79- 112.

Sayın.M.(2016)Kas Gevşeticiler Yüksel Keçik (Ed.)Temel Anestezi(s.131-152)Ankara:Güneş Tıp Kitapevi

Savarese JJ, Caldwell JE, Lien CA, Miller RD. Pharmacology of muscle relaxants and their antagonists. In: Miller RD Anesthesia, 5th ed. Philadelphia: Churchill Livingstone; 2000. p 412-90

Howland R.D.,Mycek M.J,(2014)FarmakolojiProf dr Filiz Onat (Çev.ED)İstanbul,Nobel Tıp Kitapevi

Creese R, Head SD, Jenkinson DF. The role of the sodium pump during prolonged end-plate currents in guinea-pig diaphragm. J Physiol 1987;384:377- 403.

Karslı B,Bigat Z.,Sinir Kas Blok Çeşitleri.Türkiye Klinikleri J anest Reanim 2005;3:131-135

Martin JAj.Neuromusculer Physiology and pharmacology.İn:Miller RD(ed)Millers Anesthesia 7thedition .Philedelphia:Churchilll Livingstone Elsevier;2010 ,341-360

Crul JF. Nöromusküler Monitorizasyon. Çeviri: Özel G, Özatamer Z. istanbul, Alemdar Ofset 1996;7-63

Eriksson, Lars I. Neuromuscular Monitoring Advancement: In Reply. Anesthesiology 2004;100:455.

Crul JF. Nöromusküler Monitorizasyon. Çeviri: Özel G, Özatamer Z. İstanbul, Alemdar Ofset 1996;7-63

Mogensen JV. Neuromuscular Monitoring. In: Miller RD ed. Anaesthesia, Philadelphia, Churchill Livingstone 2000;1351-66

Crofts SL. Clinical Monitoring of neuromuscular function. Br J Hos Med 1992;48:633-40

Thompson C. Monitoring the neuromusculer junction. Anaesthesia Lectures 1997;1-9.

Yavaşoğlu B.(2003)Nöromüsküler İleti ve Kas Gevşetici İlaçlar Gülsen Korfalı(Ed)Anestezide Temel Konular(s37-45) İstanbul,Nobel Tıp Kitapevi

Organe G,Paton WD,Zaimis EJ.Preliminary trials of bistrimethylamonium decane at pentane diiodode(C-10 andC-5)in man.Lancet 1949 Jan 1; 1:21-23.

Bowman WC. Pharmacology of Neuromuscular Function, 2 nd ed. London: Wright, 1990.

ÖZCENGiZ D. Kas Gevşeticiler NUEROMUSCULAR BLOCKERS Turkiye Klinikleri J Anest Reanim 2005, 3:116-131

Donnelly AJ,Cunningham FE,BaughmanVL,Anesthesiology and critical care handbook.4th edition.Lexi-Comp.;Inc.;2001,1-917

Donati F,Bevan DR.Neuromusculer blocking agents.In:Barash PG,Cullen BF,Stoelting RK(ED).Clinical Anesthesia,5th edition.Philadelpha:Lippincott Williams;2006,421-452.

Butterworth.J. ,Mackey D., Wasnick.J(2021) Morgan & Mikhail Klinik Anesteziyoloji, 6.baskı(Prof. Dr. F. Handan Cuhruk Çev.Ed.)Ankara:Güneş Tıp Kitapevi

Morgan EG, Mikhail MS, Murray M. Clinical Anesthesiology.3 th ed. McGraw-Hill; 2002. p.192-7.

Miller RD,Rupp SM,Fisher DM,et all.Clinical pharmacology of vecuronium and atracurium.Anesthesiology 1984;61:444-453

Morgan GE, Mikhail MS, Murray MJ. Clinical Anesthesiology: Cholinesterase inhibitors. Third ed. New York: Mc Graw-Hill; 2002. p.199-205.

Kayhan Z. Klinik Anestezi: Sinir kas iletimi ve kas gevşeticiler. 3.Baskı. İstanbul: Logos Yayıncılık; 2004. s.151- 80.

Demirel E, Ünal N. Kas gevşeticiler ve klinik kullanımı. Özatamer O, Alkış N, , Batislam Y, Küçük D. Anestezide Güncel Konular. 1.Baskı. Ankara: Nobel Matbaacılık;2002.s.125-59

Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005 Oct;103(4):695-703. [PubMed]

Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology. 2007 Feb;106(2):283-8. [PubMed]

Cameron KS, Clark JK, Cooper A, Fielding L, Palin R, Rutherford SJ, Zhang MQ. Modified gamma-cyclodextrins and their rocuronium complexes. Org Lett. 2002 Oct 03;4(20):3403-6. [PubMed]

Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology. 2008 Aug;109(2):188-97. [PubMed]

Togioka BM, Yanez D, Aziz MF, Higgins JR, Tekkali P, Treggiari MM. Randomised controlled trial of sugammadex or neostigmine for reversal of neuromuscular block on the incidence of pulmonary complications in older adults undergoing prolonged surgery. Br J Anaesth. 2020 May;124(5):553-561. [PubMed]

Flockton EA, Mastronardi P, Hunter JM, Gomar C, Mirakhur RK, Aguilera L, Giunta FG, Meistelman C, Prins ME. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine. Br J Anaesth. 2008 May;100(5):622-30. [PubMed]

Hunter JM, Naguib M. Sugammadex-induced bradycardia and asystole: how great is the risk? Br J Anaesth. 2018 Jul;121(1):8-12. [PubMed]

Miyazaki Y, Sunaga H, Kida K, Hobo S, Inoue N, Muto M, Uezono S. Incidence of Anaphylaxis Associated With Sugammadex. Anesth Analg. 2018 May;126(5):1505-1508. [PubMed]

Min KC, Woo T, Assaid C, McCrea J, Gurner DM, Sisk CM, Adkinson F, Herring WJ. Incidence of hypersensitivity and anaphylaxis with sugammadex. J Clin Anesth. 2018 Jun;47:67-73. [PubMed]